Good to see 6 studies reporting data between 2 half and 4th quarter this year + one early next year.
Very broad clinical trial program funded by the research institutes... glad to see patients are living longer pushing back the reporting of data and with this many studies finally beginning to report I bet there is some good news. We would be paying x5 operating expenses if we were funding these studies and the results would still be the same.
Reading all 9 patients reported positive results in one study alone and the next expansion adds another 70+ patients is an excellent outcome.
Hopefully EVT will show some great results given it too reports this year on its initial study under Kazia ownership.
Looking forward to seeing some actual data released.
